Corneal stimulation of MMP-1, -9 and uPA by platelet-activating factor is mediated by cyclooxygenase-2 metabolites

Current Eye Research

Volumn 23, Issue 2, 2001, Pages 77-85

  Ottino, Paulo ^a   Bazan, Haydee E P ^a  

^a LSU EYE CENTER   (United States)

Author keywords

Cornea; COX 2 inhibitors; MMPs; Platelet activating factor; Prostaglandins

Indexed keywords

CASEIN; CYCLOOXYGENASE 2; GELATIN; GELATINASE B; INTERSTITIAL COLLAGENASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; THROMBOCYTE ACTIVATING FACTOR; UROKINASE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPPLEMENTATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CORNEA; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ENZYME INDUCTION; ISOENZYMES; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; NITROBENZENES; ORGAN CULTURE TECHNIQUES; PLATELET ACTIVATING FACTOR; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RABBITS; SULFONAMIDES; URINARY PLASMINOGEN ACTIVATOR;

EID: 0036246457     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.23.2.77.5471     Document Type: Article

References (43)

1. Metalloproteinases and their inhibitors in matrix remodeling
2. Structural biochemistry and activation of matrix metalloproteinases
3. Matrix metalloproteinases
4. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea
5. Latent and active plasminogen activator in corneal ulceration
6. Mechanism of basement membrane dissolution preceding corneal ulceration
7. Platelet activating factor (PAF) accumulation correlates with injury in the cornea
8. Platelet-activating factor enhances urokinase-type plasminogen activator gene expression in corneal epithelium
9. Platelet-activating factor induces collagenase expression in corneal epithelial cells
10. Platelet-activating factor induces the expression of metalloproteinases-1 and -9, but not -2 or -3 in the corneal epithelium
11. Platelet-activating factor induces cyclooxygenase-2 gene expression in corneal epithelium
12. Platelet-activating factor preferentially stimulates the phospholipase A2/cylooxygenase cascade in the rabbit cornea
13. PAF binding to a single receptor in corneal epithelium plasma membrane
14. Inflammation-induced stimulation of the synthesis of prostaglandins and lipoxygenase reaction products in rabbit cornea
15. The effect of indomethacin on prostaglandin E2 in human cornea and conjunctiva
16. Response of inflammatory lipid mediators following corneal injury
17. Prostaglandins increase matrix metalloproteinases release from human ciliary smooth muscle cells
18. Prostaglandin I2 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast
19. Stimulation of matrix metalloproteinases-dependent migration of T cells by eicosanoids
20. Prostaglandins increase proMMP-1 and proMMP-3 secretion by human ciliary smooth muscle cells
21. Cyclooxygenase-2 as a therapeutic target
22. Anti-inflammatory drugs and their mechanism of action
23. Nons-teroidal antiinflammatory drugs inhibit cyclooxygenase-2 enzyme activity but not mRNA expression in human macrophages
24. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plas-minogen and casien
25. Detergent-activation of latent collagenase and resolution of its component molecules
26. Nonsteroidal drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
27. Galardin inhibits collagen degradation by rabbit keratocytes by inhibiting the activation of pro-matrix metalloproteinases
28. Proteolytic mechanisms in corneal ulceration and repair
29. Preclinical and clinical studies of MMP inhibitors in cancer
30. Engineering of selective TIMPs
31. Effect of galardin on collagen degradation by Pseudomonas Aeriginosa
32. Collagenolytic/Gelatinolytic enzymes in corneal would healing
33. Increased platelet-activating factor receptor gene expression by corneal epithelial wound healing
34. V-src induces prostaglandin syn-thase 2 gene expression by activation of the c-Jun N-terminal kinase and the c-Jun transcription factor
35. Overview of nimesulide
36. NS398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
37. NS398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxy-genase (COX-2) activity in vitro
38. Initial clinical studies with prostaglandins and their analogs
39. Clinical evaluation of UF-021 (Rescula; isopropyl unoprostane)
40. 2 levels
41. The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat
42. Complex role of matrix metalloproteinases in angiogenesis
43. The regulation of neovascularization of matrix metalloproteinases and their inhibitors